Sunitinib as Second-line Treatment in Advanced Biliary Tract Carcinoma
Clinical trial NCT01082809 · COMPLETED
Trial details
- NCT number
- NCT01082809
- Sponsor
- Samsung Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2012-01-01
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.